These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8995557

  • 61. CA 125: a valid marker in ovarian carcinoma patients treated with paclitaxel?
    Davelaar EM, Bonfrer JM, Verstraeten RA, ten Bokkel Huinink WW, Kenemans P.
    Cancer; 1996 Jul 01; 78(1):118-27. PubMed ID: 8646707
    [Abstract] [Full Text] [Related]

  • 62. Antineoplastic activity of two taxol derivatives on an ovarian tumor xenografted into nude mice.
    Riondel J, Jacrot M, Nissou MF, Picot F, Bériel H, Mouriquand C, Potier P.
    Anticancer Res; 1988 Jul 01; 8(3):387-90. PubMed ID: 2898915
    [Abstract] [Full Text] [Related]

  • 63. Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinum.
    du Bois A, Lück HJ, Buser K, Meerpohl HG, Sessa C, Klaassen U, Meden H, Bochtler H, Diergarten K.
    Eur J Cancer; 1997 Mar 01; 33(3):379-84. PubMed ID: 9155520
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Taxanes in ovarian cancer treatment.
    Seetalarom K, Kudelka AP, Verschraegen CF, Kavanagh JJ.
    Curr Opin Obstet Gynecol; 1997 Feb 01; 9(1):14-20. PubMed ID: 9090476
    [Abstract] [Full Text] [Related]

  • 69. [A clinical report of refractory carcinoma of ovary and fallopian tube treated with taxol].
    Cai S, Tang J, Fan J.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar 01; 17(2):135-8. PubMed ID: 7656806
    [Abstract] [Full Text] [Related]

  • 70. Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer.
    Phillips KA, Friedlander M, Olver I, Evans B, Smith J, Fitzharris B, McCrystal M, Joughin J, Bishop J.
    Aust N Z J Med; 1995 Aug 01; 25(4):337-43. PubMed ID: 8540875
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.
    Gore ME, Levy V, Rustin G, Perren T, Calvert AH, Earl H, Thompson JM.
    Br J Cancer; 1995 Oct 01; 72(4):1016-9. PubMed ID: 7547214
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study.
    Fu X, Zhang Y, Wang X, Chen M, Wang Y, Nie J, Meng Y, Han W.
    Curr Protein Pept Sci; 2015 Oct 01; 16(4):329-36. PubMed ID: 25929868
    [Abstract] [Full Text] [Related]

  • 75. Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
    Trimble EL, Adams JD, Vena D, Hawkins MJ, Friedman MA, Fisherman JS, Christian MC, Canetta R, Onetto N, Hayn R.
    J Clin Oncol; 1993 Dec 01; 11(12):2405-10. PubMed ID: 7902426
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. [High effectiveness of taxol in advanced ovarian cancer].
    Med Klin Suppl; 1993 Nov 01; 2():7-10. PubMed ID: 7904720
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.